Aktuelles

Psychose & Schizophrenie Forum ❤️

Herzlich willkommen in unserer hilfsbereiten Community. ✨ Hier findest du Austausch mit Betroffenen, Angehörigen und Experten – ein Ort, an dem du deine Symptome und Erfahrungen verarbeiten kannst.

Registriere dich jetzt und nutze alle Vorteile:

  • 🌐 Ein aktives Forum mit Chat- und PN-Funktion
  • 💊 Medikamente-Empfehlung ← Empfehlung bei Kognitiv- und Negativsymptomen für mehr Lebensqualität
  • 💙 Eine unterstützende Community, die an deiner Seite steht

Wir freuen uns darauf, dich in unserer Gemeinschaft zu begrüßen! ☀️

Nach dem Login wird dieses Textfeld automatisch ausgeblendet.

💊 Medication Recommendation for Psychosis – Schizophrenia – Long Version

  • Aufrufe Aufrufe: 279
  • Letzte Aktualisierung Letzte Aktualisierung:

  • 💊Medication Recommendation for Psychosis – Full Version

    Intermittent Therapy with Aripiprazole & Bupropion
    Revision Date: Sep 19, 2025

    🧭 Therapy overview

    This medication recommendation aims to achieve long-term stabilization of positive symptoms, negative symptoms, and cognitive impairments—the latter often being particularly difficult to treat and severely limiting for many individuals.

    The approach is based on the intermittent use of Aripiprazole in response to early warning signs, combined with continuous administration of Bupropion as a stabilizing base. Complementary substances such as Citalopram, Trimipramine, and nutritional supplements assist in regulating co-occurring symptoms including sleep disturbances, inner restlessness, and tendencies toward addictive behavior.

    This concept draws from over a decade of personal experience as well as initial positive feedback from the forum. It represents a patient-led perspective, built around individual symptom patterns and pharmacological reasoning.
    🧠 Benefits of Bupropion
    Bupropion enhances alertness and concentration, promoting greater safety in daily life and reducing positive symptoms. This contributes significantly to therapeutic success. Clearer perception and improved cognition help diminish thought distortions, thereby lowering the risk of delusions. In the event of a psychotic trigger, individuals can analyze more reflectively and respond with corrective actions more swiftly.

    During discontinuation intervals, bupropion notably reduces irritability and inner restlessness. These symptoms typically return only months after stopping aripiprazole. Lower restlessness makes it easier to deal with triggers without reacting impulsively to every symptom. This creates distance from the experience and fosters reflective behavior, especially in paranoid conversational patterns.

    Even negative symptoms like lack of drive and cognitive limitations nearly vanish during withdrawal phases — a strong argument for using bupropion as a stabilizing component.

    This therapy presupposes a degree of self-reflection and is especially promising for patients who have experienced relapses or possess substantial insight into their condition.


    🌳 A Metaphorical Explanation of Interval Therapy
    The psyche resembles an overgrown tree — initially, the wild branches, symbolizing mental chaos, must be pruned. For this, classical high-potency antipsychotics are suitable in inpatient settings.

    During the stabilization phase, depot-like or sedating medications such as risperidone can be helpful — at least for the first few months up to a year.

    Subsequently, tolerability becomes paramount. Activating agents like aripiprazole or cariprazine are more suitable here, particularly because they offer strong D2 blockade despite partial agonism, and complement classical agents like flupentixol or haloperidol. Even small doses, around 5 mg aripiprazole, can be reliably effective for both maintenance and acute treatment — depending on individual factors.


    🔄 Advantages of Aripiprazole in Interval Therapy
    Aripiprazole provides reliable acute efficacy and leads to less treatment resistance than risperidone. Since many patients eventually discontinue their medications — or experience relapses despite adherence — switching to aripiprazole can offer renewed hope.

    This progress, combined with good tolerability, is crucial for motivation and reclaiming quality of life. Mild residual symptoms under aripiprazole may even promote better self-assessment, reflection, and resilience.

    The idea of completely suppressing all symptoms is a therapeutic utopia. Certain fears, narcissistic or paranoid elements can be a kind of emergency response system of the body, reacting to real threats.

    Flexible dosing — with phases of increased and reduced intake — can help process symptoms and initiate necessary life changes. A psychotic overshoot can serve as a wake-up call for critical transformation.


    🧩 The Role of Affected Individuals & Social Context
    Those affected often exhibit more temperamental, anxious, and sensitive traits. Therapy must not merely act as sedation. They require medications that don’t completely dull self-perception.

    Interval therapy with bupropion enables stability without suppressing psychological expression. Positive symptoms are delayed for months, and the effect of antidepressants in active phases gets “reset.”

    Over the years, a steady improvement in positive symptoms emerges, potentially enabling a return to functional everyday life.


    💬 Conclusion: Value and Recognition
    People with mental illness rely on healthy individuals just as much as the reverse is true. Yet society often lacks appreciation for their abilities.

    Many want to work — but existing systems often overwhelm them. Unskilled jobs, disability quotas, and lack of perspective create structural hurdles. Instead, development through time and therapy should take priority — without performance pressure.

    Mental disorders like schizophrenia can be bridges. They force change when strength was lacking. Even a psychosis — despite the burden — can be the starting point for profound life improvements.
    en_Intervall.png


    🔁 Transition & Sequence​

    Starting Point: Daily administration of aripiprazole → stabilization and existing baseline therapy.

    Transition Phase:
    • Gradual introduction of Bupropion (starting at 150 mg → slow increase to 300–450 mg due to seizure risk).
    • If needed: Add Citalopram (for emotional dampening & prophylaxis).
    • For sleep disturbances or addiction risks: Add Trimipramine or Trazodone.

    ⏳ Intermittent Administration​

    After successful transition to Bupropion:
    • Discontinue Aripiprazole for approx. 2–8 months.
    • Then take Aripiprazole continuously for approx. 1–3 weeks.
    Aripiprazole should be taken based on early warning signs (e.g. rapid thought acceleration, insomnia, irritability, mistrust, etc.) → Administer for 1–3 weeks until symptoms stabilize, then discontinue again for another 2–8 months.

    💡 Antidepressants regain their full efficacy once aripiprazole is reintroduced.The effects of bupropion and citalopram gradually diminish during the 2–8 month phase without aripiprazole. A brief reintroduction of aripiprazole (2–3 weeks) refreshes the antidepressant effect, allowing them to unfold their full efficacy again during the next discontinuation interval.
    🛌 Bupropion may disrupt sleep – trimipramine reliably regulates this, but should be dosed carefully to avoid residual sedation in the morning.


    🗂️ Medication Plan – Dosages & Active Ingredients

    Active SubstanceApplication & DosagePrimary Effect
    Aripiprazole5–10 mg for 1–3 weeks at early warning signsPositive symptoms, re-stabilization, sleep support, depression
    Bupropion300–450 mg daily (start at 150 mg)Positive symptoms, cognition, negative symptoms, restlessness, irritability, smoking cessation
    Citalopram10–40 mg daily (also prophylactic); Escitalopram: ½ dosageEmotional regulation, libido moderation, supports bladder/bowel function
    Trimipramine10–20 drops in evening (40 mg/ml), optionalSleep disturbance, sedation, addiction prevention
    Vitamin B6 / B-Complex / Magnesiume.g. B6: 50–100 mg/day; higher if neededRestlessness, akathisia, mood swings, autonomic stability
    ⚠️ Note: For higher doses of vitamin B6 (200–1200 mg) used in the treatment of akathisia, strict medical supervision is required — prolonged intake above 200 mg carries a risk of neuropathy.

    🔄 Intermittent Strategy​

    • Aripiprazole is not taken continuously, but instead used for 1–3 weeks during early warning symptoms
    • This is followed by pause phases of 2–8 months, during which Bupropion provides ongoing support
    • Bupropion and other antidepressants are especially effective in the first few months after Aripiprazole is discontinued; their effect gradually diminishes over time
    • Upon recurrence of early warning signs, Aripiprazole is reintroduced
    💡 CYP2D6 Alert: Bupropion inhibits CYP2D6, resulting in a 40–80% increase in Aripiprazole plasma levels. Therapeutic Drug Monitoring (TDM) is recommended.
    💡 Tip: At the beginning of a new cycle, a slightly higher Aripiprazole dose for a few days can accelerate stabilization — particularly if the interval was missed and quick response is needed. This is due to Aripiprazole’s long half-life.

    ⚠️ Risks of Delayed Reintroduction​

    • After extended periods without Aripiprazole, symptoms such as depression, positive symptoms, irritability, and sleep disturbances may re-emerge
    • Typical early warning signs include increasing restlessness, accelerated thinking, and mood swings
    • Potential risks: delusion, mania, addiction, irritability, and in rare cases even catatonia
    • Important to note: The intermittent strategy is not full discontinuation — rather, it is a need-based reintroduction of Aripiprazole

    💤 Supportive Therapies During Activation​

    • Trimipramine or Trazodone can help manage sleep disturbances and reduce addiction risks
    • During activated phases (“newborn feeling”), behavioral addictions may intensify — such as alcohol, compulsive shopping, or gambling → counteract early with mild sedatives
    • Optional: Use Naltrexone when addiction dynamics are pronounced

    💡 Effects of SSRI and SNDRI

    1. Citalopram (SSRI) or Sertraline (SSRI) help reduce intense emotionality and heightened libido. They can also alleviate urinary retention and constipation, which may occur with Bupropion (SNDRI)
    2. Escitalopram (SSRI) is also suitable and works effectively at half the dose
    3. The emotionally dampening effect of SSRIs can support mood stabilization — but they should only be added once Bupropion has been properly stabilized. This sequence is important, as combining Aripiprazole with an SSRI too early can occasionally lead to nervous agitation — a side effect that Bupropion (as an SNDRI) can help mitigate due to its unique mechanism of action.
    4. Bupropion (SNDRI) counteracts inner restlessness and irritability (!), which is especially important during the temporary discontinuation phases of antipsychotic treatment.

    🧪 Trazodone as SARI - Alternative or supplement to SSRIs​

    • For isolated sleep disturbances, 100 mg of Trazodone in the evening is typically sufficient.
    • At higher doses (200–300 mg), Trazodone exhibits mild to moderate SSRI-like effects and may substitute for a conventional SSRI in some cases.
    • Due to overlapping serotonergic mechanisms, combining SSRI + Trazodone should only be considered under strict clinical monitoring, especially in psychotic disorders, to reduce the risk of serotonin syndrome and unpredictable interactions.
    📊 Comparison of SERT Reuptake Inhibition:
    SubstanceDoseKi at human SERT (nM)Estimated SERT Occupancy
    Citalopram20 mg1–280–90 %
    Trazodone100 mg600–1,00010–15 %
    Trazodone200–300 mg600–1,00020–30 %
    Ki = inhibition constant; lower value = higher binding potency SERT Occupancy = percentage of serotonin transporters blocked in vivo


    🔹 Core Components of the Strategy

    1. Intermittent Use of Aripiprazole

    • Taken for approx. 1–3 weeks during early warning symptoms, followed by a pause of 2 to 6 months
    • Goal: Short-term symptom control – especially stabilization of positive symptoms
    • After discontinuation: notable improvement in negative symptoms and cognition (in combination with Bupropion)
    • Aripiprazole should be reintroduced briefly if symptoms begin to worsen
    💡 Important: Since Bupropion is a CYP2D6 inhibitor, Aripiprazole blood levels may rise by approx. 40–80% – dose adjustment is advised. Therapeutic drug monitoring (TDM) is recommended.

    2. Continuous Intake of Bupropion (SNDRI)

    • Dosage: 300–450 mg daily (gradual titration recommended)
    • Effects:
      • Enhances cognition and reduces negative symptoms
      • Calms inner agitation, irritability, and mood swings
      • Supports smoking cessation through dopamine effects
    • Limitation: Its effectiveness decreases after approx. 4–6 months → Aripiprazole needs to be reintroduced to maintain stability
    🔎 Note: Bupropion is not effective against addictions such as alcohol, gambling, or compulsive shopping – additional support is needed in those cases.

    3. Adjunctive Therapy During Intervals

    SSRI Antidepressants (Citalopram, Sertraline or Escitalopram)
    • Regulate emotional reactivity and libido
    • Improve depressive symptoms
    • Help with urinary retention or constipation potentially caused by Bupropion
    ⚠️ May cause restlessness during transition → Bupropion should be stabilized first

    Tricyclic Antidepressants or SARI (Trimipramine drops or Trazodone)
    • Trimipramine: strongly sedating, may cause daytime fatigue
    • Trazodone: gentler, less residual sedation
    • Used for sleep disturbances and addiction prevention, especially in activated phases with elevated drive (“reborn feeling”)

    SARI (Trazodone) as an Alternative or Addition to SSRI
    • For isolated sleep disturbances, 100 mg of Trazodone in the evening is typically sufficient.
    • At higher doses (200–300 mg), Trazodone exhibits mild to moderate SSRI-like effects and may substitute for a conventional SSRI in some cases.
    • Due to overlapping serotonergic mechanisms, combining SSRI + Trazodone should only be considered under strict clinical monitoring, especially in psychotic disorders, to reduce the risk of serotonin syndrome and unpredictable interactions.

    📊 Comparison of SERT Reuptake Inhibition:
    SubstanceDoseKi at human SERT (nM)Estimated SERT Occupancy
    Citalopram20 mg1–280–90 %
    Trazodone100 mg600–1,00010–15 %
    Trazodone200–300 mg600–1,00020–30 %
    Ki = inhibition constant; lower value = higher binding potency SERT Occupancy = percentage of serotonin transporters blocked in vivo

    4. Addiction Risk and Prevention

    • Antipsychotic-free interval phases often come with increased drive and a “reborn feeling” → elevates risk for alcohol, gambling, and shopping addiction
    • Even brief use of Aripiprazole can trigger compulsive behavior in some cases
    • Trimipramine or Trazodone can be protective, optionally combined with Naltrexone
    • ➕Bupropion is especially effective in treating nicotine dependence, as it reduces craving via dopamine & noradrenaline reuptake inhibition

    5. Nutritional Supplementation

    • Vitamin B6 (50–100 mg/day): alleviates inner agitation and may reduce akathisia
    • Magnesium & B-complex vitamins: support general stability and nervous system balance
    • Niacin (Vitamin B3): improves circulation and may provide neurobiological benefits
    ⚠️ At higher doses (400–1200 mg/day), B6 requires medical supervision – above 200 mg, there's risk of peripheral neuropathy

    🧬 Interactions & CYP2D6 Inhibition

    • Aripiprazole is metabolized via CYP2D6 and CYP3A4
    • Bupropion inhibits CYP2D6, leading to a ~40–80% increase in Aripiprazole plasma concentration (AUC)
    • No gold-standard study exists quantifying the exact interaction — Therapeutic Drug Monitoring (TDM) is recommended
    • Other substances metabolized through CYP2D6 may be similarly affected
    • Genetic variations such as CYP2D6 polymorphisms (e.g., poor metabolizer status) should be considered
    📊 Estimated Increase in Aripiprazole AUC (blood levels):
    Interacting DrugEstimated Increase in Aripiprazole AUC
    Quinidine+100–120%
    Paroxetine+80–120%
    BupropionEstimated: +40–80%
    📚 Reference: Current assessment


    📚 Evidence-Based Studies​

    • Bupropion for negative symptoms in schizophrenia [1][2][3]
    • Bupropion for smoking cessation [4][5][6]
    • Trimipramine as an antidepressant-effective neuroleptic [7]
    • Combination strategies in psychiatric treatment and care [8]
    🗨️ Quote from the literature: "The risk of Bupropion-induced psychosis appears negligible. The combined noradrenaline and dopamine mechanism is biologically plausible. Future studies should focus on negative symptoms and cognitive function."


    🗣️ Experience from Forum Users

    schizophrenie-forum.com​

    • Dankmemes420(schizoaffective disorder), July 31, 2020: “I started Bupropion and Abilify in December 2019. After a few weeks, people noticed I was no longer so sluggish and tired. Since I’m only schizoaffective, I can especially report improvement in negative symptoms. I now live a nearly normal, structured daily life.” Original Thread
    • alisun(motivation & concentration), seen June 2025: “Bupropion helped me significantly with focus and motivation. Since reducing Olanzapine, I’ve noticed its effects growing stronger — a great medication.” Experience Thread
    • Maggi(administrator – turning point), May 14, 2025: “For me, starting Bupropion was the real turning point — I’ve had a clearer mind and much more energy ever since.” Quoted Post
    • Subrim(derealization), July 29, 2022: “I suffered from intense derealization for over three years. Just one week after starting Bupropion, my perception suddenly normalized — like discovering the world anew.” Forum Thread

    schizophrenie-online.com​

    • mango(May 27, 2019) “Bupropion helped me a lot, and I felt well-adjusted and very satisfied with my medication combination. After several years of initially severe negative symptoms, I am now largely symptom-free.” Original Thread
    • Hanseatic(May 27, 2019) “I've been taking Bupropion for two weeks and felt a certain inner restlessness. That subsided quickly, and I feel normal again. I go to work, take long bike rides on weekends, and function quite well.” Original Post
    • Hanseatic(July 2, 2020) “The restlessness faded completely after a few days. My mind is clear again. My psychiatrist said I no longer exhibit a flattened affect — I feel much more stable.” Follow-up Entry

    schizophrenie-online.org​

    • Brillenschlange(October 29, 2023) “I had taken Wellbutrin (Bupropion) 150 mg, increased to 300 mg in the clinic during a severe acute depression, and discontinued it after six weeks with medical approval — I was so stable that I no longer needed it.” Original Post
    • windlicht(October 29, 2023) “Started Wellbutrin (Bupropion) with 150 mg in the morning, then increased to 300 mg — made me feel awake and energized, helped enormously with persistent fatigue.” Forum Thread
    • Julia93(October 28, 2023) “After stopping Cipralex, I switched to Bupropion — just a few days later, my lack of drive was noticeably reduced and I was able to sleep better again.” User Experience
    🧠 Several reports from the forum and external sources suggest that Bupropion may enhance engagement in psychotherapy — possibly due to improved attention and activation.


    💡 Supplementary Usage Notes​

    • Driving & operating machinery: Aripiprazole may impair concentration — caution is advised, especially if drowsiness occurs
    • Bupropion, by contrast, promotes alertness and may improve attentional performance
    • Dynamic of effects: Antidepressants tend to be most effective shortly after Aripiprazole is discontinued — their impact wanes over the months, requiring reintroduction
    • Early warning signs such as irritability, mistrust, sleep disturbances, and emotional flooding often signal the need for renewed stabilization


    🚗 Everyday Usability & Safety​

    • Concentration may be reduced while taking Aripiprazole — caution advised when driving or operating machinery
    • Bupropion typically improves wakefulness and focus, supporting driving capability
    • Medication effects may shift over time — regular self-monitoring and medical consultation are strongly recommended

    Sag einfach Bescheid, ob ich mit dem nächsten Abschnitt zur self-application disclaimer weitermachen soll. Ich halte Stil und Struktur wie gewohnt klar und konsistent!



    📌Notes on Self-Application​

    This concept represents a structured, patient-led recommendation — not a formal medical treatment guideline All medication decisions should be made in consultation with qualified medical professionals Special caution is advised in cases of polypharmacy, unusually high dosages, or coexisting medical conditions



    🧩 Conclusion

    This patient-driven therapeutic approach offers a customizable strategy to reduce the burden of continuous medication, target negative symptoms, and manage psychotic episodes based on early warning signs.

    The combination of:
    • Targeted Aripiprazole administration
    • Continuous Bupropion therapy
    • Individually tailored adjunct medication
    … enables improved stability, everyday functioning, and quality of life — with ongoing professional feedback and observation.

    It provides a differentiated, practical treatment pathway for psychosis, with reduced pharmacological load and sustained efficacy across negative symptoms, cognition, and positive symptoms. Early warning signs serve as a guiding framework for interval adjustments, making the concept personally applicable and responsive.

    → short version ←

    Current print version

  • Laden…
  • Laden…
Zurück
Oben